ResearcherGhent University HospitalActive in the last 2 years

Nele Vandenbussche

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3341-3261; OpenAlex author ID A5045133629. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 2 papers

Papers 2

EMT-associated bias in the Parsortix® system observed with pancreatic cancer cell lines. Co-author DOI 10.1002/1878-0261.70066 ↗
Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicente… Co-author DOI 10.1186/s12893-025-02938-1 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kathleen Claes · 2 shared papers, 2025 · strength 0.45
- Paper EMT-associated bias in the Parsortix® system observed with pancreatic cancer cell lines. DOI 10.1002/1878-0261.70066 ↗
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1 ↗
L.F. Abreu de Carvalho · 1 shared paper, 2025 · strength 0.20
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1 ↗
Karen Paula Geboes · 1 shared paper, 2025 · strength 0.20
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1 ↗
Frederik Christiaan Berrevoet · 1 shared paper, 2025 · strength 0.20
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1 ↗
Filip Gryspeerdt · 1 shared paper, 2025 · strength 0.20
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.